GENEPSO : chohorte nationale prospective de personnes porteuses d'une mutation sur les gènes BRCA1 et BRCA2 : Prédispositions génétiques au cancer du sein (2e partie)FOURME, E; PICARD, C; MANCHE-THEVENOT, M. L et al.La Lettre du sénologue. 2009, Num 43, pp 10-11, issn 1289-2505, 2 p.Article

BRCA2 monoclonal antibodies react with differentiating epitheliumGILLIAM, Lisa K; LOBENHOFER, Edward K; GREER, Paula K et al.Hybridoma and hybridomics. 2002, Vol 21, Num 4, pp 261-269, issn 1536-8599, 9 p.Article

Physicians' Experiences With BRCA1/2 Testing in Community SettingsKEATING, Nancy L; STOECKERT, Kathryn A; REGAN, Meredith M et al.Journal of clinical oncology. 2008, Vol 26, Num 35, pp 5789-5796, issn 0732-183X, 8 p.Article

Nuclear localization of Rad51B is independent of Rad51C and BRCA2MILLER, Kristi A; HINZ, John M; YAMADA, N. Alice et al.Mutagenesis. 2005, Vol 20, Num 1, pp 57-63, issn 0267-8357, 7 p.Article

Recommendations for follow-up care of individuals with an inherited predisposition to Cancer. II. BRCA1 and BRCA2BURKE, W; DALY, P. M; THOMSON, E et al.JAMA, the journal of the American Medical Association. 1997, Vol 277, Num 12, pp 997-1003, issn 0098-7484Article

BRCA2 Fine-Tunes the Spindle Assembly Checkpoint through Reinforcement of BubR1 AcetylationCHOI, Eunhee; PARK, Pil-Gu; LEE, Hyunsook et al.Developmental cell. 2012, Vol 22, Num 2, pp 295-308, issn 1534-5807, 14 p.Article

Parent Opinions Regarding the Genetic Testing of Minors for BRCA1/2BRADBURY, Angela R; PATRICK-MILLER, Linda; JACKSON, Sarah et al.Journal of clinical oncology. 2010, Vol 28, Num 21, pp 3498-3505, issn 0732-183X, 8 p.Article

The case against BRCA 1 and 2 testingCHERYL LIN; SASAKI, Tina; STRUMWASSER, Aaron et al.Surgery. 2011, Vol 149, Num 6, pp 731-734, issn 0039-6060, 4 p.Article

Secondary mutations of BRCA1/2 and drug resistanceDHILLON, Kiranjit K; SWISHER, Elizabeth M; TANIGUCHI, Toshiyasu et al.Cancer science. 2011, Vol 102, Num 4, pp 663-669, issn 1347-9032, 7 p.Article

A High-Throughput Pharmaceutical Screen Identifies Compounds with Specific Toxicity against BRCA2-Deficient TumorsEVERS, Bastiaan; SCHUT, Eva; JONKERS, Jos et al.Clinical cancer research (Print). 2010, Vol 16, Num 1, pp 99-108, issn 1078-0432, 10 p.Article

Microcephalin Regulates BRCA2 and Rad51-Associated DNA Double-Strand Break RepairXIANGLIN WU; MONDAL, Gourish; XIANSHU WANG et al.Cancer research (Chicago, Ill.). 2009, Vol 69, Num 13, pp 5531-5536, issn 0008-5472, 6 p.Article

BRCA2 regulates homologous recombination in response to DNA damage : Implications for genome stability and carcinogenesisABAJI, Christine; COUSINEAU, Isabelle; BELMAAZA, Abdellah et al.Cancer research (Baltimore). 2005, Vol 65, Num 10, pp 4117-4125, issn 0008-5472, 9 p.Article

Functional evaluation and cancer risk assessment of BRCA2 unclassified variantsKANGJIAN WU; HINSON, Shannon R; OHASHI, Akihiro et al.Cancer research (Baltimore). 2005, Vol 65, Num 2, pp 417-426, issn 0008-5472, 10 p.Article

Pathology of ovarian cancers in BRCA1 and BRCA2 carriersLAKHANI, Sunil R; MANEK, Sanjiv; MEIJERS-HEIJBOER, Hanne et al.Clinical cancer research. 2004, Vol 10, Num 7, pp 2473-2481, issn 1078-0432, 9 p.Article

Comment proposer des essais d'hormonoprophylaxie aux femmes porteuses d'une mutation sur les gènes BRCA1 ou BRCA2 ? : Prédispositions génétiques au cancer du sein (2e partie) = How to propose trials of hormonal prevention to the carrier women mutation on the genes BRCA1 or BRCA2?PIOLLET-CALMETTE, I; DREYFUS, H.La Lettre du sénologue. 2009, Num 43, pp 23-27, issn 1289-2505, 5 p.Article

Fanconi anemia is associated with a defect in the BRCA2 partner PALB2BING XIA; DORSMAN, Josephine C; WEIDONG WANG et al.Nature genetics. 2007, Vol 39, Num 2, pp 159-161, issn 1061-4036, 3 p.Article

Founder mutations in BRCA1 and BRCA2 genesFERLA, R; CALO, V; CASCIO, S et al.Annals of oncology. 2007, Vol 18, issn 0923-7534, vi93-vi98, SUP6Conference Paper

Absence of rearrangements in the BRCA2 gene in human cancersCHIN, S-F; WANG, Q; PUISIEUX, A et al.British journal of cancer. 2001, Vol 84, Num 2, pp 193-195, issn 0007-0920Article

Online Tool to Guide Decisions for BRCA1/2 Mutation CarriersKURIAN, Allison W; MUNOZ, Diego F; RUST, Peter et al.Journal of clinical oncology. 2012, Vol 30, Num 5, pp 497-506, issn 0732-183X, 10 p.Article

Novel BRCA2-interacting protein BJ-HCC-20A inhibits the induction of apoptosis in response to DNA damageTOMIYOSHI, Go; NAKANISHI, Akira; TAKENAKA, Katsuya et al.Cancer science. 2008, Vol 99, Num 4, pp 747-754, issn 1347-9032, 8 p.Article

Genetic and histopathologic evaluation of BRCA1 and BRCA2 DNA sequence variants of unknown clinical significanceCHENEVIX-TRENCH, Georgia; HEALEY, Sue; SCHOLL, Tom et al.Cancer research (Baltimore). 2006, Vol 66, Num 4, pp 2019-2027, issn 0008-5472, 9 p.Article

A novel BRCA2-binding protein and breast and ovarian tumorigenesisKING, Mary-Claire.The New England journal of medicine. 2004, Vol 350, Num 12, pp 1252-1253, issn 0028-4793, 2 p.Article

Pathologie du cancer héréditaire du sein = Pathology of hereditary breast cancerSCHMITT, F. C; FILHO, J. S; MILANEZI, F et al.Le Sein (Paris). 2001, Vol 11, Num 4, pp 296-302, issn 1163-1961Article

BRCA1, BRCA2 and their possible function in DNA damage responseKOTE-JARAI, Z; EELES, R. A.British journal of cancer. 1999, Vol 81, Num 7, pp 1099-1102, issn 0007-0920Article

Ethnic differences in cancer risk resulting from genetic variationNEUHAUSEN, S. L.Cancer. 1999, Vol 86, Num 11, pp 2575-2582, issn 0008-543X, SUPConference Paper